Stenting and medical therapy for atherosclerotic renal-artery stenosis

New England Journal of Medicine

Volumn 370, Issue 1, 2014, Pages 13-22

  Cooper, Christopher J ^a   Murphy, Timothy P ^b,c   Cutlip, Donald E ^d,e   Jamerson, Kenneth ⁱ   Henrich, William ^j   Reid, Diane M ^k   Cohen, David J ^l   Matsumoto, Alan H ^m   Steffes, Michael ⁿ   Jaff, Michael R ^f   Prince, Martin R ^o   Lewis, Eldrin F ^g   Tuttle, Katherine R ^p   Shapiro, Joseph I ^q   Rundback, John H ^r   Massaro, Joseph M ^d   D'Agostino Sr , Ralph B ^d,h   Dworkin, Lance D ^a,c  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o WEILL CORNELL MEDICAL CENTER   (United States)

^p UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^q MARSHALL UNIVERSITY   (United States)

^r Holy Name Medical Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS ATORVASTATIN; CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE; AMLODIPINE; AMLODIPINE, ATORVASTATIN DRUG COMBINATION; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DRUG COMBINATION; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL ARTERY STENT; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; DRUG COMBINATION; FOLLOW UP; HYPERTENSION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENT; TREATMENT FAILURE;

AGED; AMLODIPINE; ANGIOPLASTY, BALLOON; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PYRROLES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENAL INSUFFICIENCY, CHRONIC; STENTS; TREATMENT FAILURE;

EID: 84892165653     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1310753     Document Type: Article

References (26)

1. Derkx FH, Schalekamp MA Renal artery stenosis and hypertension. Lancet 1994;344:237-9.
2. Ram CV. Renovascular hypertension. Curr Opin Nephrol Hypertens 1997; 6: 575-9.
3. Olin JW, Melia M, Young J.R., Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990;88:46N-51N.
4. Harding MB, Smith LR, Himmelstein S.I., et al Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2: 1608-16.
5. Hansen KJ, Edwards MS, Craven T.E., et al Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36: 443-51.
6. Goldblatt H, Lynch J, Hanzal R.F., Summerville WW Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347-79.
7. Blum U, Krumme B, Flügel P, et al Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-65.
8. Burket MW, Cooper CJ, Kennedy D.J., et al Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000; 139: 64-71.
9. Harden PN, MacLeod MJ, Rodger R.S., et al Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997;349:1133-6.
10. Watson PS, Hadjipetrou P, Cox S.V., Piemonte TC, Eisenhauer AC Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-7.
11. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 2004;183:561-8.
12. van Jaarsveld B.C., Krijnen P, Pieterman H., et al The effect of balloon angioplasty on hypertension in atherosclerotic renalartery stenosis. N Engl J Med 2000; 342: 1007-14.
13. Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension 1998;31:823-9.
14. Webster J, Marshall F, Abdalla M., et al Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 1998; 12: 329-35.
15. The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361:1953-62.
16. Bax L, Woittiez AJ, Kouwenberg H.J., et al Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009; 150: 840-8.
17. Cooper CJ, Murphy TP, Matsumoto A, et al Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66.
18. Stevens LA, Coresh J, Greene T., Levey AS Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-83.
19. Chobanian AV, Bakris GL, Black H.R., et al The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
21. Foy A, Ruggiero NJ II, Filippone EJ Revascularization in renal artery stenosis. Cardiol Rev 2012;20:189-93.
22. Yu H, Zhang D, Haller S., et al Determinants of renal function in patients with renal artery stenosis. Vasc Med 2011; 16: 331-8.
23. Trinquart L, Mounier-Vehier C, Sapoval M., Gagnon N, Plouin PF Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56: 525-32.
24. Rocha-Singh K., Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005; 46: 776-83.
25. Jaff MR, Bates M, Sullivan T., et al Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv 2012; 80: 343-50.
26. Rocha-Singh K., Jaff MR, Lynne Kelley E. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv 2008; 72: 853-62.